Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -5,215 | -78 | 47 | 36 | 1,518 |
| Depreciation Amortization | 4,361 | 1,065 | 698 | 387 | 29 |
| Income taxes - deferred | -744 | -749 | -483 | -348 | -118 |
| Accounts receivable | 809 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,744 | N/A | N/A | N/A | N/A |
| Other Working Capital | -4,853 | 128 | 508 | 197 | 111 |
| Other Operating Activity | -1,184 | -1,889 | -1,342 | -722 | -3,099 |
| Operating Cash Flow | $-8,569 | $-1,523 | $-572 | $-450 | $-1,559 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -17 | N/A | N/A | N/A | N/A |
| Net Acquisitions | -6,253 | -3,670 | N/A | N/A | N/A |
| Purchase Of Investment | -585,825 | -401,238 | -199,726 | -132,812 | -722,541 |
| Sale Of Investment | 653,554 | 402,337 | 200,079 | 133,166 | 725,189 |
| Other Investing Activity | -4,201 | -93 | -367 | -327 | -2,923 |
| Investing Cash Flow | $57,258 | $-2,664 | $-14 | $27 | $-274 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 371 | N/A | N/A | N/A | N/A |
| Debt Issued | -3,844 | N/A | N/A | N/A | 3,000 |
| Debt Repayment | -1 | 1,000 | N/A | N/A | N/A |
| Common Stock Issued | -33,141 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -4,764 | 4,225 | -325 | -325 | 0 |
| Financing Cash Flow | $-41,379 | $5,225 | $-325 | $-325 | $3,000 |
| Exchange Rate Effect | -82 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 1,169 | 1,169 | 1,169 | 1,169 | 2 |
| End Cash Position | 8,397 | 2,208 | 259 | 422 | 1,169 |
| Net Cash Flow | $7,228 | $1,039 | $-911 | $-747 | $1,167 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,569 | -1,523 | -572 | -450 | -1,559 |
| Capital Expenditure | -3 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -8,573 | -1,523 | -572 | -450 | -1,559 |